Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol. 2010;55:872 8. 106. O'Brien RJ, Squire IB, Demme B, et al. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF. Eur J Heart Fail. 2003;5:499 506. 107. Cohen-Solal A, Logeart D, Huang B, et al. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associ- ated with improved survival in patients with severe acutely decompen- sated heart failure. J Am Coll Cardiol. 2009;53:2343 8. 108. Salah K, Kok WE, Eurlings LW, et al. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporat- ing N-terminal pro-B-type natriuretic peptide levels: a European coLlabo- ration on Acute decompeNsated Heart Failure: ELAN-HF Score. Heart. 2014;100:115 25. 109. Flint KM, Allen LA, Pham M, et al. B-type natriuretic peptide predicts 30- day readmission for heart failure but not readmission for other causes. J Am Heart Assoc. 2014;3:e000806. 110. Kociol RD, Horton JR, Fonarow GC, et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail. 2011;4:628 36. 111. Kociol RD, McNulty SE, Hernandez AF, et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail. 2013;6:240 5. 112. Verdiani V, Ognibene A, Rutili MS, et al. NT-ProBNP reduction percent- age during hospital stay predicts long-term mortality and readmission in heart failure patients. J Cardiovasc Med (Hagerstown). 2008;9:694 9. 113. Bayes-Genis A, Lopez L, Zapico E, et al. 